Elise M. Pelletier

Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies

Jennie H. Best, Byron J. Hoogwerf, William H. Herman et al. · Diabetes Care · 2010 · 252 citations · Full text

Triple oxygen isotopes in the water cycle

Phoebe Aron, Naomi E. Levin, Emily J. Beverly et al. · Chemical Geology · 2020 · 133 citations

Engineering, Isotope Geochemistry, Oxygen Isotope +3

Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: Results from an analysis of data from a US claims database

Elise M. Pelletier, Sarika Ogale, Elaine Yu et al. · Clinical Therapeutics · 2009 · 81 citations

Economics, Healthcare Value, Economic Outcomes +11

Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis

Elise M. Pelletier, Boyung Shim, Seth Goodman et al. · Breast Cancer Research and Treatment · 2007 · 70 citations

Neuro-oncology, Cancer Epidemiology, Health Economics +12

Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting

Elise M. Pelletier, Paula Smith, Kristina S. Boye et al. · Applied Health Economics and Health Policy · 2008 · 59 citations

Diabetes Management, Health Economics, Health Policy +11